BackSenti Biosciences Overview

Senti Biosciences Total Liabilities

Track Senti Biosciences's total liabilities ($37M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$36.51M
16.82% YoYΔ $-7.38M vs prior year quarter

Peer trimmed avg / median

Loading

Senti Biosciences Total Liabilities History

Loading

Senti Biosciences vs. peers: Total Liabilities Comparison

Loading

Senti Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Senti Biosciences (SNTI) FAQ

The latest total liabilities for SNTI is $37M as of June 2026. That compares with $44M in the prior-year period — down 16.8% year over year. Investors often review this figure alongside Senti Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SNTI's total liabilities moved from $44M to $37M — a 16.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Senti Biosciences's operating scale or balance-sheet position.

A total liabilities figure of $37M for SNTI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SNTI's total liabilities ($37M), review year-over-year change from $44M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.